Simultaneous Single-Sample Determination of NMNAT Isozyme Activities in Mouse Tissues

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Orsomando, Giuseppe ^a   Cialabrini, Lucia ^a   Amici, Adolfo ^a   Mazzola, Francesca ^a   Ruggieri, Silverio ^a   Conforti, Laura ^b   Janeckova, Lucie ^c   Coleman, Michael P ^c   Magni, Giulio ^d  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c BABRAHAM INSTITUTE   (United Kingdom)

^d UNIVERSITY OF CAMERINO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE;

ANIMAL TISSUE; ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LOCALIZATION; GAIN OF FUNCTION MUTATION; IN VITRO STUDY; MOUSE; NERVE FIBER; NERVE FUNCTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; VALIDATION PROCESS;

ANIMALS; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; LIVER; MICE; NICOTINAMIDE-NUCLEOTIDE ADENYLYLTRANSFERASE;

ANIMALIA; MAMMALIA; MUS MUSCULUS; WALLERIA;

EID: 84871751837     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053271     Document Type: Article

References (44)

1. Kornberg A, (1948) The participation of inorganic pyrophosphate in the reversible enzymatic synthesis of diphosphopyridine nucleotide. J Biol Chem 176: 1475-1476.
2. Conforti L, Janeckova L, Wagner D, Mazzola F, Cialabrini L, et al. (2011) Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration. FEBS J 278: 2666-2679.
3. Hughes KT, Ladika D, Roth JR, Olivera BM, (1983) An indispensable gene for NAD biosynthesis in Salmonella typhimurium. J Bacteriol 155: 213-221.
4. Imai S, (2009) From heterochromatin islands to the NAD World: a hierarchical view of aging through the functions of mammalian Sirt1 and systemic NAD biosynthesis. Biochim Biophys Acta 1790: 997-1004.
5. Khan JA, Tao X, Tong L, (2006) Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents. Nat Struct Mol Biol 13: 582-588.
6. Hasmann M, Schemainda I, (2003) FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res 63: 7436-7442.
7. Zhai RG, Rizzi M, Garavaglia S, (2009) Nicotinamide/nicotinic acid mononucleotide adenylyltransferase, new insights into an ancient enzyme. Cell Mol Life Sci 66: 2805-2818.
8. Magni G, Di Stefano M, Orsomando G, Raffaelli N, Ruggieri S, (2009) NAD(P) biosynthesis enzymes as potential targets for selective drug design. Curr Med Chem 16: 1372-1390.
9. Lau C, Niere M, Ziegler M, (2009) The NMN/NaMN adenylyltransferase (NMNAT) protein family. Front Biosci 14: 410-431.
10. Magni G, Amici A, Emanuelli M, Orsomando G, Raffaelli N, et al. (2004) Structure and function of nicotinamide mononucleotide adenylyltransferase. Curr Med Chem 11: 873-885.
11. Koch-Nolte F, Fischer S, Haag F, Ziegler M, (2011) Compartmentation of NAD+-dependent signalling. FEBS Lett 585: 1651-1656.
12. Jayaram HN, Kusumanchi P, Yalowitz JA, (2011) NMNAT expression and its relation to NAD metabolism. Curr Med Chem 18: 1962-1972.
13. Sorci L, Cimadamore F, Scotti S, Petrelli R, Cappellacci L, et al. (2007) Initial-rate kinetics of human NMN-adenylyltransferases: substrate and metal ion specificity, inhibition by products and multisubstrate analogues, and isozyme contributions to NAD+ biosynthesis. Biochemistry 46: 4912-4922.
14. Berger F, Lau C, Dahlmann M, Ziegler M, (2005) Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms. J Biol Chem 280: 36334-36341.
15. Garavaglia S, D'Angelo I, Emanuelli M, Carnevali F, Pierella F, et al. (2002) Structure of human NMN adenylyltransferase. A key nuclear enzyme for NAD homeostasis. J Biol Chem 277: 8524-8530.
16. Brunetti L, Di Stefano M, Ruggieri S, Cimadamore F, Magni G, (2010) Homology modeling and deletion mutants of human nicotinamide mononucleotide adenylyltransferase isozyme 2: new insights on structure and function relationship. Protein Sci 19: 2440-2450.
17. Raffaelli N, Sorci L, Amici A, Emanuelli M, Mazzola F, et al. (2002) Identification of a novel human nicotinamide mononucleotide adenylyltransferase. Biochem Biophys Res Commun 297: 835-840.
18. Lau C, Dolle C, Gossmann TI, Agledal L, Niere M, et al. (2010) Isoform-specific targeting and interaction domains in human nicotinamide mononucleotide adenylyltransferases. J Biol Chem 285: 18868-18876.
19. Zhang X, Kurnasov OV, Karthikeyan S, Grishin NV, Osterman AL, et al. (2003) Structural characterization of a human cytosolic NMN/NaMN adenylyltransferase and implication in human NAD biosynthesis. J Biol Chem 278: 13503-13511.
20. Di Stefano M, Galassi L, Magni G, (2010) Unique expression pattern of human nicotinamide mononucleotide adenylyltransferase isozymes in red blood cells. Blood Cells Mol Dis 45: 33-39.
21. Chen L, Petrelli R, Felczak K, Gao G, Bonnac L, et al. (2008) Nicotinamide adenine dinucleotide based therapeutics. Curr Med Chem 15: 650-670.
22. Nikiforov A, Dolle C, Niere M, Ziegler M, (2011) Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation. J Biol Chem 286: 21767-21778.
23. Mayer PR, Huang N, Dewey CM, Dries DR, Zhang H, et al. (2010) Expression, localization, and biochemical characterization of nicotinamide mononucleotide adenylyltransferase 2. J Biol Chem 285: 40387-40396.
24. Berger F, Lau C, Ziegler M, (2007) Regulation of poly(ADP-ribose) polymerase 1 activity by the phosphorylation state of the nuclear NAD biosynthetic enzyme NMN adenylyl transferase 1. Proc Natl Acad Sci U S A 104: 3765-3770.
25. Magni G, Orsomando G, Raffelli N, Ruggieri S, (2008) Enzymology of mammalian NAD metabolism in health and disease. Front Biosci 13: 6135-6154.
26. Belenky P, Bogan KL, Brenner C, (2007) NAD+ metabolism in health and disease. Trends Biochem Sci 32: 12-19.
27. Feng Y, Yan T, He Z, Zhai Q, (2010) Wld(S), NMNATs and axon degeneration-progress in the past two decades. Protein Cell 1: 237-245.
28. Coleman MP, Freeman MR, (2010) Wallerian degeneration, Wld(S), and NMNAT. Annu Rev Neurosci 33: 245-267.
29. Wang J, He Z, (2009) NAD and axon degeneration: from the Wlds gene to neurochemistry. Cell Adh Migr 3: 77-87.
30. Sasaki Y, Vohra BP, Lund FE, Milbrandt J, (2009) Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide. J Neurosci 29: 5525-5535.
31. Raff MC, Whitmore AV, Finn JT, (2002) Axonal self-destruction and neurodegeneration. Science 296: 868-871.
32. Lunn ER, Perry VH, Brown MC, Rosen H, Gordon S, (1989) Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur J Neurosci 1: 27-33.
33. Coleman MP, Adalbert R, Beirowski B, (2005) Neuroprotective strategies in MS: lessons from C57BL/Wld(S) mice. J Neurol Sci 233: 133-138.
34. Conforti L, Adalbert R, Coleman MP, (2007) Neuronal death: where does the end begin? Trends Neurosci 30: 159-166.
35. Wang J, Zhai Q, Chen Y, Lin E, Gu W, et al. (2005) A local mechanism mediates NAD-dependent protection of axon degeneration. J Cell Biol 170: 349-355.
36. Gilley J, Coleman MP, (2010) Endogenous NMNAT2 is an essential survival factor for maintenance of healthy axons. PLoS Biol 8: e1000300.
37. Balducci E, Emanuelli M, Raffaelli N, Ruggieri S, Amici A, et al. (1995) Assay methods for nicotinamide mononucleotide adenylyltransferase of wide applicability. Anal Biochem 228: 64-68.
38. Trench WF, Kolman B (1972) Multivariable Calculus with Linear Algebra and Series. In: Academic Press NY, editor, p. 82.
39. Pfaffl MW, Horgan GW, Dempfle L, (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30: e36.
40. Mack TG, Reiner M, Beirowski B, Mi W, Emanuelli M, et al. (2001) Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/NMNAT chimeric gene. Nat Neurosci 4: 1199-1206.
41. Conforti L, Tarlton A, Mack TG, Mi W, Buckmaster EA, et al. (2000) A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proc Natl Acad Sci U S A 97: 11377-11382.
42. Raches DW, Xiao S, Kusumanchi P, Yalowitz J, Sanghani P, et al. (2011) Cloning, expression and characterization of mouse (Mus musculus) nicotinamide 5′-mononucleotide adenylyltransferase-2. Med Chem 7: 718-726.
43. Yahata N, Yuasa S, Araki T, (2009) Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration. J Neurosci 29: 6276-6284.
44. Beirowski B, Babetto E, Gilley J, Mazzola F, Conforti L, et al. (2009) Non-nuclear Wld(S) determines its neuroprotective efficacy for axons and synapses in vivo. J Neurosci 29: 653-668.